FGF23 and cardiac hypertrophy: Furthermore, a decrease of soluble Klotho in CKD was reported to be an important cause of uremic cardiomyopathy or to inhibit renal fibrosis in an FGF23-independent manner [21, 22], while FGF23 can induce myocardial hypertrophy independent of Klotho [10].